Breast Cancer Clinical Trials in Miami, FL

Breast Cancer Clinical Trials in Miami, FL

View the best 10 breast cancer medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Breast Cancer clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for breast cancer in Miami, Florida

Image of USC Norris Comprehensive Cancer Center in Los Angeles, United States.

PC14586 +1 More

Small Molecule

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Image of Kaiser Permanente - Oakland in Oakland, United States.

Letrozole +2 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial will compare two treatments for breast cancer: giredestrant with palbociclib, and letrozole with palbociclib. The trial will measure how well the treatments work and how safe they are.
Image of Sarah Cannon Research Institute in Nashville, United States.

TC-510

CAR T-cell Therapy

Recruiting1 awardPhase 1 & 2
This trial tests TC-510, a therapy using a patient's own modified T cells to target and attack cancer cells. It is aimed at patients with cancers that are hard to treat with standard methods. The modified T cells are designed to recognize specific proteins on cancer cells and get an extra boost to kill them.
Image of Research Site in Little Rock, United States.

Dato-DXd

Antibody-drug conjugate

Recruiting2 awardsPhase 3
This trial is testing a new treatment for patients with a specific type of breast cancer who still have cancer after surgery and initial treatments. The treatment uses a drug called Dato-DXd, which targets and kills cancer cells, and may also include durvalumab, which helps the immune system fight cancer. The goal is to see if this new treatment works better than current options.
Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Decision Aid

Recruiting1 award22 criteria
This trial is testing web-based tools to help patients with early stage breast cancer make decisions about treatment. The goal is to learn how best to implement these tools in clinical practice.
Image of Memorial Sloan Kettering Basking Ridge (All Protocol Activities) in Basking Ridge, United States.

SDX-7320 +1 More

Recruiting0 awardsPhase 2
This trial is testing whether adding SDX-7320 to standard chemotherapy eribulin helps people with TNBC and metabolic dysfunction, and whether it is safe.
Image of University of Alabama at Birmingham in Birmingham, United States.

Risk-based Breast Cancer Screening Schedule

Behavioural Intervention

Recruiting1 award4 criteria
This trial is comparing annual breast cancer screening to a risk-based breast cancer screening schedule. The goal is to see if the risk-based schedule detects breast cancers earlier and causes fewer false positives.
Image of Indiana University Melvin and Bren Simon Comprehensive Cancer Center in Indianapolis, United States.

Talazoparib +2 More

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether different targeted therapies can improve outcomes for women with residual Triple Negative Breast Cancer after pre-operative treatment.
Image of The Oncology Institute of Hope and Innovation in Whittier, United States.

BAY 2927088

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial is looking for a new way to treat advanced non-small cell lung cancer (NSCLC) with specific genetic changes called HER2 mutations. They are testing a new treatment called BAY
Image of St. Bernards Medical Center in Jonesboro, United States.

Imlunestrant

Selective Estrogen Receptor Downregulator (SERD)

Recruiting2 awardsPhase 3
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.